The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
Top Cited Papers
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (3) , 923-928
- https://doi.org/10.1016/j.bmcl.2007.12.047
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Fracture Incidence and Characterization in Patients on Osteoporosis Treatment: The ICARO StudyJournal of Bone and Mineral Research, 2006
- A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeysBone, 2006
- Structure Activity Relationships of 5-, 6-, and 7-Methyl-Substituted Azepan-3-one Cathepsin K InhibitorsJournal of Medicinal Chemistry, 2006
- Trifluoroethylamines as amide isosteres in inhibitors of cathepsin KBioorganic & Medicinal Chemistry Letters, 2005
- Design and Synthesis of Tri-Ring P3 Benzamide-Containing Aminonitriles as Potent, Selective, Orally Effective Inhibitors of Cathepsin KJournal of Medicinal Chemistry, 2005
- Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional SelectivityJournal of Medicinal Chemistry, 2005
- P2–P3 conformationally constrained ketoamide-based inhibitors of cathepsin KBioorganic & Medicinal Chemistry Letters, 2005
- Inhibition of the Cysteine Protease Cathepsin K (EC 3.4.22.38)Published by Elsevier ,2004
- A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin KJournal of Medicinal Chemistry, 2003
- Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient miceProceedings of the National Academy of Sciences, 1998